1. Home
  2. VGAS vs RFL Comparison

VGAS vs RFL Comparison

Compare VGAS & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verde Clean Fuels Inc.

VGAS

Verde Clean Fuels Inc.

N/A

Current Price

$2.73

Market Cap

63.9M

Sector

Industrials

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.46

Market Cap

54.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VGAS
RFL
Founded
2007
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Real Estate
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
63.9M
54.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VGAS
RFL
Price
$2.73
$1.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
9.7K
143.0K
Earning Date
11-13-2025
12-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,029,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
47.63
52 Week Low
$2.49
$1.17
52 Week High
$4.39
$3.19

Technical Indicators

Market Signals
Indicator
VGAS
RFL
Relative Strength Index (RSI) 45.04 64.11
Support Level $2.65 $1.21
Resistance Level $2.79 $1.60
Average True Range (ATR) 0.19 0.08
MACD 0.02 0.04
Stochastic Oscillator 43.93 67.44

Price Performance

Historical Comparison
VGAS
RFL

About VGAS Verde Clean Fuels Inc.

Verde Clean Fuels Inc is a renewable energy company specializing in the conversion of synthesis gas, or syngas, derived from diverse feedstocks, such as biomass, MSW, and mixed plastics, as well as natural gas (including synthetic natural gas) and other feedstocks, into liquid hydrocarbons that can be used as gasoline through a proprietary liquid fuels technology, the STG process.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

Share on Social Networks: